Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Individual difference in toxic diffuse goiters assessed by heme-based specific activity and Km value

Y Hosaka1, T Ishii, N Suzuki

  • 1Faculty of Pharmaceutical Sciences, Chiba University, Japan.

Endocrine Journal
|February 1, 1993
PubMed
Summary

Thyroid peroxidase (TPO) was purified from patients with toxic diffuse goiter. Purified TPO showed higher activity and specific activity in one experiment, suggesting potential impairment from sample handling in another.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Factor IX inhibition and epitope localization of factor IX inhibitor antibodies in haemophilia B patients with anaphylactoid reactions.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd report.

Haemophilia : the official journal of the World Federation of Hemophilia·2012
Same author

An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.

Haemophilia : the official journal of the World Federation of Hemophilia·2011
Same author

Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trial.

Haemophilia : the official journal of the World Federation of Hemophilia·2011

Area of Science:

  • Biochemistry
  • Endocrinology
  • Immunology

Background:

  • Thyroid peroxidase (TPO) is a key enzyme in thyroid hormone synthesis.
  • Toxic diffuse goiter is a condition characterized by an overactive thyroid gland.
  • Understanding TPO's properties is crucial for diagnosing and treating thyroid disorders.

Purpose of the Study:

  • To purify thyroid peroxidase (TPO) from patients with toxic diffuse goiter using an improved method.
  • To characterize the kinetic properties and heme concentration of purified TPO.
  • To compare TPO activity and properties between different patient groups and with porcine TPO.

Main Methods:

  • Simplified purification of TPO using monoclonal anti-TPO antibody-assisted immunoaffinity column chromatography.
  • Measurement of heme concentration via cyanide difference spectrum.

Related Experiment Videos

  • Determination of kinetic parameters (Km, kcat) using guaiacol and iodide as substrates.

    • Main Results:

    • Purified TPO from experiment 1 (10 patients) exhibited higher heme-based specific activities than from experiment 2 (4 patients).
    • Differences in kinetic properties were observed between experiment 1 and experiment 2 TPO.
    • Lower activity in experiment 2 was potentially due to sample impairment from freezing-thawing.

    Conclusions:

    • The simplified immunoaffinity chromatography method effectively purified TPO from human thyroids.
    • Sample handling, such as freezing-thawing, can impact TPO activity and kinetic properties.
    • Further studies are needed to fully elucidate the variations in TPO characteristics in toxic diffuse goiter.